This AOP is licensed under the BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
AOP: 645
Title
Binding and activation of AhR lead to cardiovascular aging
Short name
Graphical Representation
Point of Contact
Contributors
- Shiheng Gui
- Ruifang Fan
Coaches
OECD Information Table
| OECD Project # | OECD Status | Reviewer's Reports | Journal-format Article | OECD iLibrary Published Version |
|---|---|---|---|---|
This AOP was last modified on July 09, 2026 09:44
Revision dates for related pages
| Page | Revision Date/Time |
|---|---|
| Aryl hydrocarbon receptor(AhR)activation | July 09, 2026 03:41 |
| Increase, Oxidative Stress | February 11, 2026 07:05 |
| Increase, DNA damage | May 08, 2019 12:28 |
| Increase, Cell cycle arrest | July 09, 2026 04:05 |
| Impact on sirtuins-related aging signaling pathway gene expression | July 09, 2026 03:52 |
| Disruption, Mitochondrial dysfunction | July 09, 2026 04:54 |
| Increase, Myocardial and vascular structural remodeling | July 09, 2026 05:00 |
| Increase, Systemic inflammation | July 09, 2026 05:02 |
| Increase, Blood pressure elevation | July 09, 2026 05:06 |
| Increase, Cardiovascular aging | July 09, 2026 05:08 |
| Increase, Telomere attrition | July 09, 2026 06:05 |
| AhR activation leads to Increase, Oxidative Stress | July 09, 2026 05:09 |
| Increase, Oxidative Stress leads to Impact on sirtuins-related aging signaling pathway gene expression | July 09, 2026 07:58 |
| Impact on sirtuins-related aging signaling pathway gene expression leads to Increase, DNA Damage | July 09, 2026 05:11 |
| Increase, DNA Damage leads to Cell cycle arrest | July 09, 2026 05:12 |
| Cell cycle arrest leads to Increase, Telomere attrition | July 09, 2026 08:11 |
| Increase, DNA Damage leads to Mitochondrial dysfunction | July 09, 2026 08:13 |
| Increase, Oxidative Stress leads to Systemic inflammation | July 09, 2026 08:14 |
| Impact on sirtuins-related aging signaling pathway gene expression leads to Myocardial and vascular structural remodeling | July 09, 2026 08:15 |
| Myocardial and vascular structural remodeling leads to Blood pressure elevation | July 09, 2026 08:15 |
| Myocardial and vascular structural remodeling leads to Cardiovascular aging | July 09, 2026 08:19 |
| Naphthalene | July 03, 2026 11:28 |
| Acenaphthene | July 09, 2026 06:10 |
| Acenaphthylene | July 09, 2026 06:14 |
| Fluorene | July 09, 2026 06:14 |
| Phenanthrene | November 29, 2016 18:42 |
| Anthracene | July 03, 2026 11:29 |
| Fluoranthene | July 09, 2026 06:28 |
| Pyrene | July 03, 2026 11:30 |
| Chrysene | July 03, 2026 11:31 |
| Benzo(b)fluoranthene | July 03, 2026 11:22 |
| Benzo(k)fluoranthene | November 29, 2016 18:42 |
| Benzo(a)pyrene | March 20, 2020 20:17 |
| Benz(a)anthracene | July 03, 2026 11:31 |
| Indeno(1,2,3-cd)pyrene | July 09, 2026 07:32 |
| Dibenz(a,h)anthracene | July 09, 2026 07:32 |
| Benzo(g,h,i)perylene | July 09, 2026 07:33 |
Abstract
This AOP aims to elucidate the key biological pathways through which polycyclic aromatic hydrocarbons (PAHs) activate the aryl hydrocarbon receptor (AhR) and promote cardiovascular aging. AhR is a ligand-dependent transcription factor that plays a central role in regulating the expression of xenobiotic metabolism and detoxification-related enzymes (such as the CYP family); simultaneously, AhR is expressed in various tissue types including vascular endothelium, and its activation is closely associated with endothelial dysfunction, inflammatory responses, and vascular remodeling processes. As exogenous pollutants, PAHs may cause multi-system damage after entering the organism. In this AOP, the binding and activation of PAHs to AhR is defined as the Molecular Initiating Event (MIE). Subsequently, AhR signaling can directly or indirectly inhibit the expression or activity of SIRT1/SIRT6, serving as Key Event 1 (KE1), and induce DNA damage responses, further leading to upregulation of p16 and p21, accompanied by aging-related changes including enhanced systemic inflammation and oxidative stress, telomere attrition, and mitochondrial dysfunction. The persistent cellular damage described above ultimately drives structural and functional remodeling of the myocardium and vasculature, manifested as increased vascular calcium deposition, elevated blood pressure, and consequently the formation of cardiovascular aging as the Adverse Outcome (AO). We have identified multiple key events in this pathway and delineated the logical relationships between key events; based on this, we have constructed this AOP to describe the molecular mechanisms by which AhR binding and activation lead to cardiovascular aging.
AOP Development Strategy
Context
Polycyclic aromatic hydrocarbons (PAHs) refer to hydrocarbon compounds containing two or more benzene rings in their molecular structure, primarily originating from incomplete combustion of organic matter(Zhang, 2017) . PAHs are widely distributed in environmental water, air, soil, and food. Dietary intake, respiration, and dermal contact are the main routes of PAH exposure, characterized by persistence, passivity, and inevitability, increasing cancer risk and causing high incidence of cardiovascular diseases. Numerous population epidemiological studies have shown that PAHs exposure are closely associated with the development of cardiovascular diseases such as hypertension, atherosclerosis, and ischemic heart disease(Curfs et al., 2004; Xu et al., 2021) . Given their widespread environmental distribution and potential toxicity, the United States Environmental Protection Agency (EPA) has listed 16 of them as priority controlled toxic organic pollutants. Therefore, it is necessary to assess the health risks of PAHs based on the AOP (Adverse Outcome Pathway) framework.
Strategy
Summary of the AOP
Events:
Molecular Initiating Events (MIE)
Key Events (KE)
Adverse Outcomes (AO)
| Type | Event ID | Title | Short name |
|---|
| MIE | 2430 | Aryl hydrocarbon receptor(AhR)activation | AhR activation |
| KE | 1392 | Increase, Oxidative Stress | Increase, Oxidative Stress |
| KE | 2431 | Impact on sirtuins-related aging signaling pathway gene expression | Impact on sirtuins-related aging signaling pathway gene expression |
| KE | 1194 | Increase, DNA damage | Increase, DNA Damage |
| KE | 2432 | Increase, Cell cycle arrest | Cell cycle arrest |
| KE | 2439 | Increase, Telomere attrition | Increase, Telomere attrition |
| KE | 2434 | Disruption, Mitochondrial dysfunction | Mitochondrial dysfunction |
| KE | 2436 | Increase, Systemic inflammation | Systemic inflammation |
| KE | 2435 | Increase, Myocardial and vascular structural remodeling | Myocardial and vascular structural remodeling |
| KE | 2437 | Increase, Blood pressure elevation | Blood pressure elevation |
| AO | 2438 | Increase, Cardiovascular aging | Cardiovascular aging |
Relationships Between Two Key Events (Including MIEs and AOs)
| Title | Adjacency | Evidence | Quantitative Understanding |
|---|
| AhR activation leads to Increase, Oxidative Stress | adjacent | Moderate | High |
| Increase, Oxidative Stress leads to Impact on sirtuins-related aging signaling pathway gene expression | adjacent | High | High |
| Impact on sirtuins-related aging signaling pathway gene expression leads to Increase, DNA Damage | adjacent | High | High |
| Increase, DNA Damage leads to Cell cycle arrest | adjacent | High | High |
| Cell cycle arrest leads to Increase, Telomere attrition | adjacent | High | High |
| Increase, DNA Damage leads to Mitochondrial dysfunction | adjacent | High | High |
| Increase, Oxidative Stress leads to Systemic inflammation | adjacent | Moderate | High |
| Impact on sirtuins-related aging signaling pathway gene expression leads to Myocardial and vascular structural remodeling | adjacent | High | High |
| Myocardial and vascular structural remodeling leads to Blood pressure elevation | adjacent | High | High |
| Myocardial and vascular structural remodeling leads to Cardiovascular aging | adjacent | Moderate | Moderate |
Network View
Prototypical Stressors
Life Stage Applicability
| Life stage | Evidence |
|---|---|
| During brain development, adulthood and aging | High |
Taxonomic Applicability
Sex Applicability
| Sex | Evidence |
|---|---|
| Male | High |
Overall Assessment of the AOP
As the DNA damage effects of PAHs are widely recognized, previous research has primarily focused on the carcinogenic, teratogenic, and mutagenic effects induced by PAH-mediated DNA damage. However, DNA damage is also an important driving factor in accelerating cellular senescence, and cellular senescence is an important pathway for suppressing cellular malignant transformation; therefore, this Adverse Outcome Pathway (AOP) focuses on the association between PAH exposure and cardiovascular aging. However, current in vivo and in vitro evidence investigating PAH exposure-induced cardiovascular toxic effects remains relatively limited. Moreover, existing in vivo or in vitro studies typically focus on single or a few PAHs, and the exposure doses set are high, making it difficult to reflect the adverse effects of mixed PAHs at environmental doses on the cardiovascular system in the general population. Therefore, low-dose mixed animal exposure, cell experiments, and computer simulation studies are needed to investigate the adverse effects of mixed exposure to 16 priority-controlled PAHs on the cardiovascular system from the perspective of aging.
This AOP takes AhR activation as the initiating event; PAHs can directly activate AhR(Das et al., 2016), then directly or indirectly inhibit the expression of SIRT1/SIRT6 in the cardiovascular system, and induce DNA damage responses, further leading to upregulation of p16 and p21, accompanied by aging-related changes including enhanced systemic inflammation and oxidative stress, telomere attrition, and mitochondrial dysfunction (Bin et al., 2010; Malik and Czajka, 2013) . Experimental results can be obtained from various models, including experimental animals, mice, and cell lines. Among these, in vivo animal experiments, in vitro experiments, and computer simulation evidence can confirm the associations between the Molecular Initiating Event (MIE) and Key Event Relationships (KERs).
Domain of Applicability
In HUVEC cells, studies have found that exposure to low doses (10-100 µM) of naphthalene, fluoranthene, and fluorene can cause Ca²⁺ ion influx, promote eNOS activation, and further lead to increased NO synthesis(Li et al., 2004) . This suggests that the negative regulatory effect between PAH exposure levels and blood pressure may be closely related to PAH-promoted NO synthesis in endothelial cells. Similarly, in HUVEC cells, exposure to environmental doses of mixed 16 priority-controlled PAHs caused inflammatory responses and oxidative stress, and significantly decreased migration and tube formation capabilities(He et al., 2022).
In rat models, after B[a]P exposure, significant increases in systolic blood pressure, diastolic blood pressure, and mean arterial pressure were observed in rats, with significantly decreased maximal acetylcholine-stimulated aortic relaxation responses(Gan et al., 2012) . In mouse models, B[a]P exposure caused systemic inflammation in apolipoprotein-deficient (ApoE⁻/⁻) mice and led to atherosclerosis development; exposure to 16 priority-controlled PAHs promoted atherosclerotic plaque formation in ApoE⁻/⁻ mice by upregulating miR-155 and inhibiting SERPIND1 expression (He et al., 2021) . Additionally, in zebrafish models, exposure to Pyr, B[a]P, and B[k]P all caused cardiac developmental abnormalities (Zhang et al., 2021).
Meanwhile, combining epidemiological surveys and experimental research results, PAH exposure has significant effects on cardiovascular aging, particularly on blood pressure, atherosclerosis formation, cardiac development, and heart rate. Existing studies have found that urinary 1-OHPhe levels in the hypertension group (0.152 µg/g) were significantly higher than those in the non-hypertension group (0.128 µg/g) (Lee et al., 2020) . Another study found that for every 1 µg/mmol increase in urinary 4-OHPhe or total -OHPAHs content, the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) increased by 12.63% or 11.91%, respectively (p < 0.05) (Yin et al., 2017) . Pregnancy and infancy are critical time windows for cardiac development, relatively sensitive to pollutant exposure. Maternal occupational PAH exposure during pregnancy increases the risk of congenital heart defects (CHD) in offspring, and among occupationally PAH-exposed populations, PAH metabolite levels are associated with decreased heart rate, with a dose-response relationship (Deng et al., 2022; Li et al., 2012).
Essentiality of the Key Events
MIE1: AhR activation
PAHs (such as benzo[a]pyrene) enter cells as ligands and bind to AhR in the cytoplasm, triggering dissociation of AhR from the molecular chaperone complex (HSP90, XAP2, p23), nuclear translocation, and heterodimer formation with ARNT, thereby binding to XRE sequences to initiate target gene transcription. AhR activation not only initiates Phase I metabolic reactions but also lays the foundation for oxidative stress and inflammatory responses.
KE1: Oxidative stress
Oxidative stress refers to the disruption of redox balance in vivo or within cells, resulting in massive production of ROS (including superoxide anion, hydrogen peroxide, and hydroxyl radicals), while simultaneously consuming intracellular antioxidant substances (GSH, SOD, CAT), exceeding the scavenging capacity of the antioxidant defense system.
KE2: Impact on sirtuins-related aging signaling pathway gene expression
Among the sirtuins family, SIRT1 and SIRT6 are known as "longevity genes" and are NAD⁺-dependent deacetylases that play important roles in maintaining mitochondrial function and integrity, DNA damage repair, telomere maintenance, and cardiovascular homeostasis.
KE3: DNA damage
ROS and PAH active metabolites (such as BPDE) directly attack DNA, forming DNA adducts and leading to double-strand breaks or base mutations.
KE4: Cell cycle arrest
Both p16INK4a and p21Cip1 are cell cycle arrest proteins. When DNA damage occurs within cells, cell cycle checkpoints are activated, cell cycle arrest protein expression increases, causing cell cycle stagnation.
KE5: Telomere attrition
Telomeres serve as protective structures at chromosome ends; their attrition (length shortening or structural dysfunction) is caused by ROS-mediated oxidative damage and end replication problems during DNA replication.
KE6: Mitochondrial dysfunction
With increasing age, various adverse factors accumulate within mitochondria, such as mtDNA mutations and changes in mitochondrial dynamics, which can cause mitochondrial dysfunction, increased ROS generation, and further increase mitochondrial membrane permeability, thereby triggering inflammation and cell death. When mtDNAcn is abnormal, mitochondria are facing stress, which is one manifestation of mitochondrial dysfunction.
KE7: Systemic inflammation
An immune process occurring within cardiovascular tissues characterized by immune cell infiltration, inflammatory factor release, tissue damage, and repair responses.
KE8: Myocardial and vascular structural remodeling
Myocardial and vascular structural remodeling includes ventricular hypertrophy, thinning and loose structure of ventricular walls, focal vascular proliferation, and disordered arrangement of vascular smooth muscle, providing structural basis for subsequent blood pressure elevation and vascular calcification.
KE9: Blood pressure elevation
Vascular aging leads to increased vascular stiffness, disordered secretion of vasoactive substances, decreased vascular diastolic regulation capacity, and increased susceptibility to hypertension. Blood pressure elevation is manifested as sustained elevation of arterial systolic or diastolic pressure; hypertension accelerates vascular remodeling and calcification.
Evidence Assessment
|
Essentiality of KE |
Definitional Question |
High (Strong) |
Moderate |
Low (Weak) |
|
If the upstream KE is blocked, will the downstream KE and/or AO be prevented? |
Direct evidence from specifically designed experimental studies indicating that at least one important KE is essential |
Indirect evidence suggesting that sufficient modification of the expected modulating factor would weaken or enhance the KE |
No or contradictory experimental evidence proving the essentiality of any KE |
|
|
KE1: Oxidative stress |
Moderate |
Extracellular signaling molecules bind and activate AhR, inducing CYP1A1/1B1 expression, metabolizing PAHs, and producing large amounts of ROS. |
||
|
KE2: Impact on sirtuins-related aging signaling pathway gene expression |
High |
The AhR/ARNT complex binds to XREs (xenobiotic response elements) in the SIRT1/SIRT6 promoter regions, inhibiting transcription. |
||
|
KE3: DNA damage |
High |
SIRT1/SIRT6 participate in DNA repair; reduced expression of both leads to decreased repair efficiency and accumulation of DNA damage. PAHs can directly and competitively bind to DNA strand binding sites in SIRT6, limiting its ability to bind damaged DNA strands, causing decreased DNA damage response capability of SIRT6, and exacerbating DNA damage in the cardiovascular system. |
||
|
KE4: Cell cycle arrest |
High |
DNA damage accumulation activates cell cycle checkpoints, cell cycle arrest proteins p16/p21 expression increases, causing stable cell cycle arrest. |
||
|
KE5: Telomere attrition |
High |
DNA damage can cause telomere dysfunction, telomere binding protein TRF2 expression is inhibited, and p53 expression is activated, thereby promoting cellular senescence or apoptosis. Telomerase activity is inhibited in senescent cells. The p53/p21 and p16/pRB pathways may synergistically limit telomerase expression. ROS continuously attacks telomere DNA. |
||
|
KE6: Mitochondrial dysfunction |
High |
DNA damage can cause mitochondrial dysfunction by inhibiting PGC-1α through p53, reducing mitochondrial biogenesis; increased ROS generation further increases mitochondrial membrane permeability, potentially causing abnormal mtDNAcn. |
||
|
KE7: Systemic inflammation |
Moderate |
Chronic inflammation caused by oxidative stress activates pathways such as NF-κB and releases pro-inflammatory cytokines such as TNF-α, causing cardiovascular system aging. |
||
|
KE8: Myocardial and vascular structural remodeling |
High |
Decreased SIRT1/SIRT6 expression causes cardiovascular aging and myocardial and vascular remodeling. Inflammatory factors promote myocardial and vascular structural remodeling. Environmental doses of PAHs cause ventricular hypertrophy in rats, while high concentrations of PAH exposure cause thinning of ventricular walls and structural dilation. High concentration PAH exposure causes focal arterial proliferation, disordered smooth muscle arrangement, and increased arterial calcium deposition, causing vascular structural changes. |
||
|
KE9: Blood pressure elevation |
High |
Decreased vascular compliance leads to increased peripheral resistance. Increased arterial stiffness leads to elevated systolic pressure and increased pulse pressure difference. |
||
|
AO: Cardiovascular aging |
High |
Cardiovascular aging caused by hypertension is usually associated with cardiovascular structural and functional abnormalities; sustained hypertension accelerates increased cardiac afterload, myocardial hypertrophy, and deterioration of vascular lesions. |
||
Known Modulating Factors
| Modulating Factor (MF) | Influence or Outcome | KER(s) involved |
|---|---|---|
Quantitative Understanding
Considerations for Potential Applications of the AOP (optional)
References
[1] Bin, P., Leng, S., Cheng, J., Pan, Z.-f., Duan, H., Dai, Y., Li, H.-s., Niu, Y., Liu, Q.-j., Liu, Q.-j., Zheng, Y.-x., 2010. [Association between telomere length and occupational polycyclic aromatic hydrocarbons exposure]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 44 6, 535-538
[2] Curfs, D.M., Lutgens, E., Gijbels, M.J., Kockx, M.M., Daemen, M.J., van Schooten, F.J., 2004. Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. Am J Pathol 164, 101-108.10.1016/s0002-9440(10)63101-x
[3] Das, D., Panda, P., Naik, P.P., Mukhopadhyay, S., Sinha, N., Bhutia, S., 2016. Phytotherapeutic approach: a new hope for polycyclic aromatic hydrocarbons induced cellular disorders, autophagic and apoptotic cell death. Toxicology Mechanisms and Methods 27, 1-54.10.1080/15376516.2016.1268228
[4] Deng, C., Pu, J., Deng, Y., Xie, L., Yu, L., Liu, L., Guo, X., Sandin, S., Liu, H., Dai, L., 2022. Association between maternal smoke exposure and congenital heart defects from a case-control study in China. Sci Rep 12, 14973.10.1038/s41598-022-18909-y
[5] Gan, T.E., Xiao, S.P., Jiang, Y., Hu, H., Wu, Y.H., Duerksen-Hughes, P.J., Sheng, J.Z., Yang, J., 2012. Effects of Benzo(a)pyrene on the Contractile Function of the Thoracic Aorta of Sprague-dawley Rats. Biomedical and Environmental Sciences 25, 549-556.https://doi.org/10.3967/0895-3988.2012.05.008
[6] He, J., Pang, Q., Huang, C., Xie, J., Hu, J., Wang, L., Wang, C., Meng, L., Fan, R., 2022. Environmental dose of 16 priority-controlled PAHs mixture induce damages of vascular endothelial cells involved in oxidative stress and inflammation. Toxicology in Vitro 79, 105296.https://doi.org/10.1016/j.tiv.2021.105296
[7] He, X.N., Xin, J.Y., Zhan, J.L., Wu, F.K., Hou, J., Sun, Z., Wang, J., Zhang, X.L., Bai, Y.C., 2021. Polycyclic aromatic hydrocarbons induce endothelial injury through miR‐155 to promote atherosclerosis. Environmental and Molecular Mutagenesis 62, 409-421.10.1002/em.22454
[8] Lee, T.W., Kim, D.H., Ryu, J.Y., 2020. Association between urinary polycyclic aromatic hydrocarbons and hypertension in the Korean population: data from the Second Korean National Environmental Health Survey (2012-2014). Sci Rep 10, 17142.10.1038/s41598-020-74353-w
[9] Li, C.-H., Lee, C.-C., Juang, H.-A., Kang, J.-J., 2004. Activation and up-regulation of nitric oxide synthase in human umbilical vein endothelial cells by polycyclic aromatic hydrocarbons. Toxicology letters 151, 367-374.10.1016/j.toxlet.2004.03.003
[10] Li, X., Feng, Y., Deng, H., Zhang, W., Kuang, D., Deng, Q., Dai, X., Lin, D., Huang, S., Xin, L., He, Y., Huang, K., He, M., Guo, H., Zhang, X., Wu, T., 2012. The dose-response decrease in heart rate variability: any association with the metabolites of polycyclic aromatic hydrocarbons in coke oven workers? PLoS One 7, e44562.10.1371/journal.pone.0044562
[11] Malik, A.N., Czajka, A., 2013. Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion 13, 481-492
[12] Xu, C., Liu, Q., Liang, J., Weng, Z., Xu, J., Jiang, Z., Gu, A., 2021. Urinary biomarkers of polycyclic aromatic hydrocarbons and their associations with liver function in adolescents. Environmental Pollution 278, 116842.https://doi.org/10.1016/j.envpol.2021.116842
[13] Yin, W., Hou, J., Xu, T., Cheng, J., Li, P., Wang, L., Zhang, Y., Wang, X., Hu, C., Huang, C., Yu, Z., Yuan, J., 2017. Obesity mediated the association of exposure to polycyclic aromatic hydrocarbon with risk of cardiovascular events. The Science of the total environment 616-617.10.1016/j.scitotenv.2017.10.238
[14] Zhang, S., Ou, K., Huang, J., Fang, L., Wang, C., 2021. In utero exposure to mixed PAHs causes heart mass reduction in adult male mice. Ecotoxicology and environmental safety 225, 112804.10.1016/j.ecoenv.2021.112804
[15] Zhang, Z., 2017. A review of polycyclic aromatic hydrocarbons (PAHs) research progress in China based on CNKI database. AIP Conference Proceedings 1820.10.1063/1.4977385